SlideShare a Scribd company logo
SUBMITTED BY
JAYA PRAKASH V
REGULATORY AFFAIRS
SVCP 218311
AGENDA
 Introduction
 Life Cycle Approach
 Life Cycle Phases
 Quality Risk Management
 Regulated Company Activities
 SupplierActivities
 INTRODUCTION
 GAMP 5 is applicable to a wide range of information
systems, lab equipment, integrated manufacturing
systems, and IT infrastructures.
 Bringing procedures in line with the dynamic Life
science industry .
 reducing the cost of compliance.
 Avoid duplication of activities (e.g. by fully integrating
engineering and computer system activities so that
they are only performed once).
 Scale all life cycle activities and associated
documentation according to risk, complexity and
novelty.
 GAMP guidance aims to achieve computerized
systems that are fit for intended use and meet
current regulatory requirements, by building upon
existing industry good practice in an efficient and
effective manner.
 The GAMP Guide contains the validation framework
and associated procedures and guidelines. It draws
together the key principles and practices, and
describes how they can be applied to determine the
extent and scope of validation for different types of
systems, ensuring that validation is scaleable.
 Facilitates the interpretation of regulatory
requirements.
 Establishes a common language and terminology.
 Promotes a system life cycle approach based on
good practice.
 Clarifies roles and responsibility.
 Focus attention on those computerised systems with
most impact on patient safety, product quality, and
data integrity .
GAMP DOCUMENTATION
STRUCTURE
Few of the Important Points
 GAMP 5 - all about risk. Increasing complexity and/or
novelty = higher risk = more effort and deliverables.
 Moving away from traditional qualification
terminology (e.g. IQ, OQ, PQ). Terminology confuses
people outside of the validation and QA
departments. Terminology is still available, but
optional.
CONT.....
 Most computerized systems now based on
configurable packages, many of them
networked.
 Validate only if there could be an impact on
patient safety, product quality, data
integrity. If none of these, no need to
validate, good engineering practice is
sufficient.
 Need to be clear on the differences
between system owner and process owner.
DRIVERS FOR GAMP-5
Life Cycle Approach Within a QMS
 defining activities in a systematic way from
understanding requirements to system retirement .
 Enables management control and a consistent
approach across systems .
 The life cycle should form an intrinsic part of the
company’s Quality Management System (QMS) .
 The QMS should enable continuous process and
system improvements based on periodic review and
evaluation, operational and performance data, and
root-cause analysis of failures .
LIFE CYCLE APPROACH
Product and Process
Understanding
 An understanding of the supported process is
fundamental .
 Focus on risk to Patient Safety, Product Quality, and
Data Integrity .
 Need to understand risks associated with a business
process before the risks associated with specific
functions of computerized systems can be assessed .
 Specification of requirements should be focused on
critical aspects .
 The extent and detail of requirement specification
should be based on the associated risk, complexity, and
novelty of the system.
LIFE CYCLE PHASES
Quality Risk Management
 Quality risk management is a systematic
process for the assessment, control,
communication, and review of risks.
 An iterative process used throughout the
entire computerized system life cycle from
concept to retirement.
 For a given organization, a framework for
making risk management decisions should be
defined to ensure consistency of application
across systems and business functions.
 Terminology should be agreed upon, particularly
regarding definitions and metrics for key risk
factors.
OVERVIEW AND BENIFITS OF
RISK MANAGEMENT
RISK ASSESSMENT
METHOD
QUALITY RISK MANAGEMENT
PROCESS
Regulated Company
Activities
 To ensure compliance
 To ensure fitness for intended use
 Achieving robust, cost effective,
compliance requires strong governance
 The activities require a defined
organizational and governance framework
 Governance is the responsibility of the
regulated company
Governance & Organisational
Management
 Identify and comply with GxP requirements
 Integrate life cycle activities into quality
management system
 Identify and assess each system
 Ensure systems compliant and fit for use
according to SOPs
 Follow a validation framework, validation plans
and reports
 Maintain compliance throughout the lifetime of a
system
System Activities for Effective
Governance
 Maintaining the system inventory.
 Impact of systems on patient safety, product quality,
data integrity.
 Defining the computerized system life cycle approach.
 Life cycle planning, supplier assessment, risk
management, specification, verification, reporting
activities and documents.
 System operation and management, operating
procedures for end users and administrators.
 Record and data management.
 Security management.
Product and Process Understanding
 An understanding of the supported process is
fundamental.
 For determining system requirements.
 As a basis for making science and risk based
decisions to assure that the system is designed
and verified to be fit for its intended use.
Regulated Company
Management
 Regulated Company Management.
 Set up the Governance Structure.
 Ensure funding for Governance.
 Ensure policies and procedures available.
 Appoint Process Owner.
 Appoint System Owner.
 Appoint Project Manager.
Supplier Activities
 Suppliers Role
 Suppliers (including internal suppliers) play an
important support role in achieving and
maintaining system compliance and fitness for
intended use
 Provide key documentation.
 Performing testing.
 Providing support e.g. change control
Stable systems designed and
developed using Good Practice
 Establish QMS.
 Establish requirements.
 Quality planning.
 Assessments of sub-suppliers.
 Produce specifications.
 Perform design review.
 Software production/ configuration.
 Perform testing.
 Commercial release of system.
 Provide user documentation and training.
 Support and maintain the system in
operations.
 System replacement and retirement
Planning in QMS
 If you want the supplier to follow your policies,
procedures and standards.
 This must be made clear in the RFP (external
supplier) and project documentation.
 Documentation must be provided.
 Supplier personnel must be trained before work
starts.
 Compliance must be assured.
 Quality Plan
 If you use the supplier’s policies,
procedures and standards
 The supplier’s practices must be assessed
for suitability, accuracy and completeness.
 Compliance must be assured throughout
the life cycle.
 Quality Plan.
 Supplier assessment.
 Supplier assessment is important
Summary
 I have presented GAMP5.
 The structure .
 Life cycle approach.
 Quality risk management.
 Life Cycle Phases.
 Regulated company activities .
 Supplier activities.
 Take a look at the document and the other
Good Practice Guides.
THANK U

More Related Content

What's hot

What's hot (20)

Good Automated Laboratory Practices
Good Automated Laboratory PracticesGood Automated Laboratory Practices
Good Automated Laboratory Practices
 
GOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICEGOOD AUTOMATED LABORATORY PRACTICE
GOOD AUTOMATED LABORATORY PRACTICE
 
21 code of federal regulation
21 code of federal regulation21 code of federal regulation
21 code of federal regulation
 
GHTF
GHTFGHTF
GHTF
 
Overview on “Computer System Validation” CSV
Overview on  “Computer System Validation” CSVOverview on  “Computer System Validation” CSV
Overview on “Computer System Validation” CSV
 
Computer System Validation
Computer System ValidationComputer System Validation
Computer System Validation
 
Auditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production DepartmentAuditing in Solid Oral Dosage Form Production Department
Auditing in Solid Oral Dosage Form Production Department
 
Gamp Riskbased Approch To Validation
Gamp Riskbased Approch To ValidationGamp Riskbased Approch To Validation
Gamp Riskbased Approch To Validation
 
Computer system validations
Computer system validationsComputer system validations
Computer system validations
 
cGMP regulations & QA function.pptx
cGMP regulations &  QA function.pptxcGMP regulations &  QA function.pptx
cGMP regulations & QA function.pptx
 
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
21 CFR-FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES...
 
Pharmaceutical Quality System
Pharmaceutical Quality SystemPharmaceutical Quality System
Pharmaceutical Quality System
 
Good Distribution Practices
Good Distribution PracticesGood Distribution Practices
Good Distribution Practices
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptx
 
CDER
CDERCDER
CDER
 
21 CFR PART 11
21 CFR PART 1121 CFR PART 11
21 CFR PART 11
 
Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)Prior Approval Supplements (PAS)
Prior Approval Supplements (PAS)
 
Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I Documentation in Pharmaceutical Industry Part I
Documentation in Pharmaceutical Industry Part I
 
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideOverview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
 
ICH Q7 GMP for API
ICH Q7 GMP for APIICH Q7 GMP for API
ICH Q7 GMP for API
 

Similar to Gamp 5 overview by jaya prakash ra

How to Implement and Maintain an Audit-Ready QMS Leveraging Technology
How to Implement and Maintain an Audit-Ready QMS Leveraging TechnologyHow to Implement and Maintain an Audit-Ready QMS Leveraging Technology
How to Implement and Maintain an Audit-Ready QMS Leveraging Technology
Greenlight Guru
 
General Validation Presentation
General Validation PresentationGeneral Validation Presentation
General Validation Presentation
markaodonnell
 
2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde
mikaelyde
 
Good Automated Manufacturing Practices(GAMP).pptx
Good Automated Manufacturing Practices(GAMP).pptxGood Automated Manufacturing Practices(GAMP).pptx
Good Automated Manufacturing Practices(GAMP).pptx
Poonam Aher Patil
 
Quality management system processes
Quality management system processesQuality management system processes
Quality management system processes
selinasimpson2801
 
Connie FarrisProject Performance and Quality Assurance(M.docx
Connie FarrisProject Performance and Quality Assurance(M.docxConnie FarrisProject Performance and Quality Assurance(M.docx
Connie FarrisProject Performance and Quality Assurance(M.docx
margaretr5
 

Similar to Gamp 5 overview by jaya prakash ra (20)

RSPL Brochure
RSPL BrochureRSPL Brochure
RSPL Brochure
 
How to Implement and Maintain an Audit-Ready QMS Leveraging Technology
How to Implement and Maintain an Audit-Ready QMS Leveraging TechnologyHow to Implement and Maintain an Audit-Ready QMS Leveraging Technology
How to Implement and Maintain an Audit-Ready QMS Leveraging Technology
 
General Validation Presentation
General Validation PresentationGeneral Validation Presentation
General Validation Presentation
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
 
Pqs220610.Ppt
Pqs220610.PptPqs220610.Ppt
Pqs220610.Ppt
 
Pqs220610.ppt
Pqs220610.pptPqs220610.ppt
Pqs220610.ppt
 
Pqs220610.Ppt
Pqs220610.PptPqs220610.Ppt
Pqs220610.Ppt
 
GOOD ENGINEERING PRACTICES
GOOD ENGINEERING PRACTICESGOOD ENGINEERING PRACTICES
GOOD ENGINEERING PRACTICES
 
Quality Management Systems - Aviation Industry
Quality Management Systems - Aviation IndustryQuality Management Systems - Aviation Industry
Quality Management Systems - Aviation Industry
 
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROsWebinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
 
The challenges facing in pharmaceutical maintenance
The challenges facing in pharmaceutical maintenanceThe challenges facing in pharmaceutical maintenance
The challenges facing in pharmaceutical maintenance
 
QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.QUALITY ASSURANCE .. quality assurance and quality control.
QUALITY ASSURANCE .. quality assurance and quality control.
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
 
Quality Management
Quality ManagementQuality Management
Quality Management
 
2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde
 
free training on Quality Management systems in software industry.Iso 9000,ISO...
free training on Quality Management systems in software industry.Iso 9000,ISO...free training on Quality Management systems in software industry.Iso 9000,ISO...
free training on Quality Management systems in software industry.Iso 9000,ISO...
 
Good Automated Manufacturing Practices(GAMP).pptx
Good Automated Manufacturing Practices(GAMP).pptxGood Automated Manufacturing Practices(GAMP).pptx
Good Automated Manufacturing Practices(GAMP).pptx
 
Quality process management
Quality process managementQuality process management
Quality process management
 
Quality management system processes
Quality management system processesQuality management system processes
Quality management system processes
 
Connie FarrisProject Performance and Quality Assurance(M.docx
Connie FarrisProject Performance and Quality Assurance(M.docxConnie FarrisProject Performance and Quality Assurance(M.docx
Connie FarrisProject Performance and Quality Assurance(M.docx
 

More from JAYA PRAKASH VELUCHURI

More from JAYA PRAKASH VELUCHURI (18)

Tangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptxTangential Flow Filtration - PPT.pptx
Tangential Flow Filtration - PPT.pptx
 
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptxBasics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
Basics of Biologics| Biosimilars| USFDA| In View of Regulatory Point.pptx
 
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSUREHUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
HUMAN CHALLENGE STUDIES TO ACCELERATE CORONA VIRUS VACCINE LICENSURE
 
FIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIAFIXED DOSE COMBINATIONS BANNED IN INDIA
FIXED DOSE COMBINATIONS BANNED IN INDIA
 
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
AN OVERVIEW ON FIXED DOSE COMBINATIONS AND ITS REGULATIONS IN INDIA
 
HOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEWHOMEOPATHY IN INDIA AND US OVERVIEW
HOMEOPATHY IN INDIA AND US OVERVIEW
 
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
FIXED DOSE COMBINATIONS REGULATIONS IN INDIA AND A CASE STUDY ON THE TOP SELL...
 
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONSIMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
IMPACT OF REGULATIONS ON MEDICAL DEVICES IN CONTEXT OF INNOVATIONS
 
CASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROLCASE STUDY ON CHANGE CONTROL
CASE STUDY ON CHANGE CONTROL
 
Registration requirments for cis countries
Registration requirments for cis countriesRegistration requirments for cis countries
Registration requirments for cis countries
 
Documentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodiumDocumentation of raw material analysis for croscarmellose sodium
Documentation of raw material analysis for croscarmellose sodium
 
Market authorisation checklist for brics countries
Market authorisation checklist for brics countriesMarket authorisation checklist for brics countries
Market authorisation checklist for brics countries
 
Response to a warning letter
Response to a warning letterResponse to a warning letter
Response to a warning letter
 
Ge health care and mri
Ge health care and mriGe health care and mri
Ge health care and mri
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
ICH AND ICH GUIDELINES
ICH AND ICH GUIDELINESICH AND ICH GUIDELINES
ICH AND ICH GUIDELINES
 
Mutual recognition
Mutual recognitionMutual recognition
Mutual recognition
 
THIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHYTHIN LAYER CHROMATOGRAPHY
THIN LAYER CHROMATOGRAPHY
 

Recently uploaded

platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
muralinath2
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
AADYARAJPANDEY1
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
PirithiRaju
 
Detectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a TechnosignatureDetectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a Technosignature
Sérgio Sacani
 

Recently uploaded (20)

platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)Microbial Type Culture Collection (MTCC)
Microbial Type Culture Collection (MTCC)
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
GEOLOGICAL FIELD REPORT On Kaptai Rangamati Road-Cut Section.pdf
GEOLOGICAL FIELD REPORT  On  Kaptai Rangamati Road-Cut Section.pdfGEOLOGICAL FIELD REPORT  On  Kaptai Rangamati Road-Cut Section.pdf
GEOLOGICAL FIELD REPORT On Kaptai Rangamati Road-Cut Section.pdf
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Transport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSETransport in plants G1.pptx Cambridge IGCSE
Transport in plants G1.pptx Cambridge IGCSE
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
 
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCINGRNA INTERFERENCE: UNRAVELING GENETIC SILENCING
RNA INTERFERENCE: UNRAVELING GENETIC SILENCING
 
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
word2vec, node2vec, graph2vec, X2vec: Towards a Theory of Vector Embeddings o...
 
electrochemical gas sensors and their uses.pptx
electrochemical gas sensors and their uses.pptxelectrochemical gas sensors and their uses.pptx
electrochemical gas sensors and their uses.pptx
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptxGLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
GLOBAL AND LOCAL SCENARIO OF FOOD AND NUTRITION.pptx
 
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdfPests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
Pests of Green Manures_Bionomics_IPM_Dr.UPR.pdf
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
Detectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a TechnosignatureDetectability of Solar Panels as a Technosignature
Detectability of Solar Panels as a Technosignature
 
Topography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of BengalTopography and sediments of the floor of the Bay of Bengal
Topography and sediments of the floor of the Bay of Bengal
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 

Gamp 5 overview by jaya prakash ra

  • 1. SUBMITTED BY JAYA PRAKASH V REGULATORY AFFAIRS SVCP 218311
  • 2. AGENDA  Introduction  Life Cycle Approach  Life Cycle Phases  Quality Risk Management  Regulated Company Activities  SupplierActivities
  • 3.  INTRODUCTION  GAMP 5 is applicable to a wide range of information systems, lab equipment, integrated manufacturing systems, and IT infrastructures.  Bringing procedures in line with the dynamic Life science industry .  reducing the cost of compliance.  Avoid duplication of activities (e.g. by fully integrating engineering and computer system activities so that they are only performed once).  Scale all life cycle activities and associated documentation according to risk, complexity and novelty.
  • 4.  GAMP guidance aims to achieve computerized systems that are fit for intended use and meet current regulatory requirements, by building upon existing industry good practice in an efficient and effective manner.  The GAMP Guide contains the validation framework and associated procedures and guidelines. It draws together the key principles and practices, and describes how they can be applied to determine the extent and scope of validation for different types of systems, ensuring that validation is scaleable.
  • 5.  Facilitates the interpretation of regulatory requirements.  Establishes a common language and terminology.  Promotes a system life cycle approach based on good practice.  Clarifies roles and responsibility.  Focus attention on those computerised systems with most impact on patient safety, product quality, and data integrity .
  • 7. Few of the Important Points  GAMP 5 - all about risk. Increasing complexity and/or novelty = higher risk = more effort and deliverables.  Moving away from traditional qualification terminology (e.g. IQ, OQ, PQ). Terminology confuses people outside of the validation and QA departments. Terminology is still available, but optional.
  • 8. CONT.....  Most computerized systems now based on configurable packages, many of them networked.  Validate only if there could be an impact on patient safety, product quality, data integrity. If none of these, no need to validate, good engineering practice is sufficient.  Need to be clear on the differences between system owner and process owner.
  • 10. Life Cycle Approach Within a QMS  defining activities in a systematic way from understanding requirements to system retirement .  Enables management control and a consistent approach across systems .  The life cycle should form an intrinsic part of the company’s Quality Management System (QMS) .  The QMS should enable continuous process and system improvements based on periodic review and evaluation, operational and performance data, and root-cause analysis of failures .
  • 12. Product and Process Understanding  An understanding of the supported process is fundamental .  Focus on risk to Patient Safety, Product Quality, and Data Integrity .  Need to understand risks associated with a business process before the risks associated with specific functions of computerized systems can be assessed .  Specification of requirements should be focused on critical aspects .  The extent and detail of requirement specification should be based on the associated risk, complexity, and novelty of the system.
  • 14. Quality Risk Management  Quality risk management is a systematic process for the assessment, control, communication, and review of risks.  An iterative process used throughout the entire computerized system life cycle from concept to retirement.
  • 15.  For a given organization, a framework for making risk management decisions should be defined to ensure consistency of application across systems and business functions.  Terminology should be agreed upon, particularly regarding definitions and metrics for key risk factors.
  • 16. OVERVIEW AND BENIFITS OF RISK MANAGEMENT
  • 19. Regulated Company Activities  To ensure compliance  To ensure fitness for intended use  Achieving robust, cost effective, compliance requires strong governance  The activities require a defined organizational and governance framework  Governance is the responsibility of the regulated company
  • 20. Governance & Organisational Management  Identify and comply with GxP requirements  Integrate life cycle activities into quality management system  Identify and assess each system  Ensure systems compliant and fit for use according to SOPs  Follow a validation framework, validation plans and reports  Maintain compliance throughout the lifetime of a system
  • 21. System Activities for Effective Governance  Maintaining the system inventory.  Impact of systems on patient safety, product quality, data integrity.  Defining the computerized system life cycle approach.  Life cycle planning, supplier assessment, risk management, specification, verification, reporting activities and documents.  System operation and management, operating procedures for end users and administrators.  Record and data management.  Security management.
  • 22. Product and Process Understanding  An understanding of the supported process is fundamental.  For determining system requirements.  As a basis for making science and risk based decisions to assure that the system is designed and verified to be fit for its intended use.
  • 23. Regulated Company Management  Regulated Company Management.  Set up the Governance Structure.  Ensure funding for Governance.  Ensure policies and procedures available.  Appoint Process Owner.  Appoint System Owner.  Appoint Project Manager.
  • 24. Supplier Activities  Suppliers Role  Suppliers (including internal suppliers) play an important support role in achieving and maintaining system compliance and fitness for intended use  Provide key documentation.  Performing testing.  Providing support e.g. change control
  • 25. Stable systems designed and developed using Good Practice  Establish QMS.  Establish requirements.  Quality planning.  Assessments of sub-suppliers.  Produce specifications.  Perform design review.  Software production/ configuration.
  • 26.  Perform testing.  Commercial release of system.  Provide user documentation and training.  Support and maintain the system in operations.  System replacement and retirement
  • 27. Planning in QMS  If you want the supplier to follow your policies, procedures and standards.  This must be made clear in the RFP (external supplier) and project documentation.  Documentation must be provided.  Supplier personnel must be trained before work starts.  Compliance must be assured.  Quality Plan
  • 28.  If you use the supplier’s policies, procedures and standards  The supplier’s practices must be assessed for suitability, accuracy and completeness.  Compliance must be assured throughout the life cycle.  Quality Plan.  Supplier assessment.  Supplier assessment is important
  • 29. Summary  I have presented GAMP5.  The structure .  Life cycle approach.  Quality risk management.  Life Cycle Phases.  Regulated company activities .  Supplier activities.  Take a look at the document and the other Good Practice Guides.